Max Healthcare Institute Limited
NSE:MAXHEALTH.NS
Sector
Industries
Location
Market Cap
USD 13.53 B
Share Price
USD 13.92
Avg Daily Volume
1,964,861
Change (1 day)
-3.92%
Change (1 year)
34.43%
Change (YTD)
5.59%
Max Healthcare Institute Limited Operating Cash Flow for the year ending March 31, 2025: USD 170.77 M
Max Healthcare Institute Limited Operating Cash Flow is USD 170.77 M for the year ending March 31, 2025, a 26.97% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Max Healthcare Institute Limited Operating Cash Flow for the year ending March 31, 2024 was USD 134.49 M, a -8.58% change year over year.
-
Max Healthcare Institute Limited Operating Cash Flow for the year ending March 31, 2023 was USD 147.12 M, a 49.25% change year over year.
-
Max Healthcare Institute Limited Operating Cash Flow for the year ending March 31, 2022 was USD 98.58 M, a 512.42% change year over year.
-
Max Healthcare Institute Limited Operating Cash Flow for the year ending March 31, 2021 was USD 16.10 M, a -51.45% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Quest Diagnostics Incorporated
USD 179.77
DGX
+1.33
0.74%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Sonic Healthcare Limited
USD 18.42
SHL.AX
-0.08
-0.42%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
Bumrungrad Hospital Public Company Limited
USD 5.63
BH.BK
-0.03
-0.61%
MediPal Holdings Corporation
USD 17.44
7459.T
+0.01
0.03%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Labcorp Holdings Inc.
USD 270.38
LH
-0.87
-0.32%
Quest Diagnostics Incorporated
USD 179.77
DGX
+1.33
0.74%
Sino Biopharmaceutical Limited
USD 1.00
1177.HK
+0.03
2.72%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Sonic Healthcare Limited
USD 18.42
SHL.AX
-0.08
-0.42%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.19
300832.SZ
+0.21
2.67%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.34
0874.HK
+0.02
0.70%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.94
600079.SS
-0.00
-0.04%
Bumrungrad Hospital Public Company Limited
USD 5.63
BH.BK
-0.03
-0.61%
MediPal Holdings Corporation
USD 17.44
7459.T
+0.01
0.03%
AddLife AB (publ)
USD 17.22
ALIF-B.ST
+0.03
0.20%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
+0.07
1.65%
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%